Lymphocyte-predominant Hodgkin's disease: how little therapy is enough?

Characterization of activating mutations of NOTCH3 in T-cell acute lymphoblastic leukemia and anti-leukemic activity of NOTCH3 inhibitory antibodies.

Oncogene·2016

A microRNA-mediated regulatory loop modulates NOTCH and MYC oncogenic signals in B- and T-cell malignancies.

Leukemia·2014

A Notch1-neuregulin1 autocrine signaling loop contributes to melanoma growth.

Oncogene·2012

High-level expression of Mastermind-like 2 contributes to aberrant activation of the NOTCH signaling pathway in human lymphomas.

Oncogene·2010

BRD-NUT oncoproteins: a family of closely related nuclear proteins that block epithelial differentiation and maintain the growth of carcinoma cells.

Oncogene·2007

Integrative analysis reveals 53BP1 copy loss and decreased expression in a subset of human diffuse large B-cell lymphomas.

Oncogene·2007

Perioperative Durvalumab for Resectable Non-Small Cell Lung Cancer: Updated Outcomes From the Phase III AEGEAN Trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Long-Term Survival Outcomes of Modified-FOLFOXIRI Plus Cetuximab Versus Bevacizumab in RAS/BRAF Wild-Type Metastatic Colorectal Cancer: Final Analysis of the DEEPER Trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Refined Continuous Risk Index for Accurately Predicting Outcomes of Patients With Chronic Lymphocytic Leukemia After Limited-Duration Therapy.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Medical Therapy for Hormone Receptor-Positive, HER2-Negative Stage I-III Breast Cancer: ASCO Living Guideline, Version 2026.1.0.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Salvage Hypofractionated Accelerated Versus Standard Radiotherapy for Biochemical Recurrence After Radical Prostatectomy: A Phase III Randomized Clinical Trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

The Patient Who Could Not Die.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

A case of diffuse large B-cell lymphoma achieving complete remission with epcoritamab after pseudoprogression.

Journal of clinical and experimental hematopathology : JCEH·2026

Cytokine-associated ROS and Ca2+ dysregulation in severe inflammatory cardiomyopathy.

Cardiovascular research·2026

Acute EBV-Associated Systemic Inflammatory Syndrome Presenting as PUO With FDG-Avid Generalized Lymphadenopathy, Autoimmune Serological Positivity and Myopericarditis Mimicking Lymphoma and Connective Tissue Disease: A Diagnostic Challenge.

Cureus·2026

Gradually Enlarging Nodular Pulmonary Amyloidosis Associated With Sjögren's Syndrome.

Respirology case reports·2026

A Case of Thyroid Dermopathy.

Cureus·2026

Immune dysregulation in osteoarthritis: Mechanisms, biomarkers, and therapeutic opportunities.

Journal of translational autoimmunity·2026

Related Experiment Videos

Lymphocyte-predominant Hodgkin's disease: how little therapy is enough?

Related Concept Videos

Characterization of activating mutations of NOTCH3 in T-cell acute lymphoblastic leukemia and anti-leukemic activity of NOTCH3 inhibitory antibodies.

A microRNA-mediated regulatory loop modulates NOTCH and MYC oncogenic signals in B- and T-cell malignancies.

A Notch1-neuregulin1 autocrine signaling loop contributes to melanoma growth.

High-level expression of Mastermind-like 2 contributes to aberrant activation of the NOTCH signaling pathway in human lymphomas.

BRD-NUT oncoproteins: a family of closely related nuclear proteins that block epithelial differentiation and maintain the growth of carcinoma cells.

Integrative analysis reveals 53BP1 copy loss and decreased expression in a subset of human diffuse large B-cell lymphomas.

Perioperative Durvalumab for Resectable Non-Small Cell Lung Cancer: Updated Outcomes From the Phase III AEGEAN Trial.

Long-Term Survival Outcomes of Modified-FOLFOXIRI Plus Cetuximab Versus Bevacizumab in RAS/BRAF Wild-Type Metastatic Colorectal Cancer: Final Analysis of the DEEPER Trial.

Refined Continuous Risk Index for Accurately Predicting Outcomes of Patients With Chronic Lymphocytic Leukemia After Limited-Duration Therapy.

Medical Therapy for Hormone Receptor-Positive, HER2-Negative Stage I-III Breast Cancer: ASCO Living Guideline, Version 2026.1.0.

Salvage Hypofractionated Accelerated Versus Standard Radiotherapy for Biochemical Recurrence After Radical Prostatectomy: A Phase III Randomized Clinical Trial.

The Patient Who Could Not Die.

A case of diffuse large B-cell lymphoma achieving complete remission with epcoritamab after pseudoprogression.

Cytokine-associated ROS and Ca2+ dysregulation in severe inflammatory cardiomyopathy.

Acute EBV-Associated Systemic Inflammatory Syndrome Presenting as PUO With FDG-Avid Generalized Lymphadenopathy, Autoimmune Serological Positivity and Myopericarditis Mimicking Lymphoma and Connective Tissue Disease: A Diagnostic Challenge.

Gradually Enlarging Nodular Pulmonary Amyloidosis Associated With Sjögren's Syndrome.

A Case of Thyroid Dermopathy.

Immune dysregulation in osteoarthritis: Mechanisms, biomarkers, and therapeutic opportunities.

Related Experiment Videos

Lymphocyte-predominant Hodgkin's disease: how little therapy is enough?

Related Concept Videos

Related Articles